Understanding the Path to Type 1 Diabetes Treatments: From Lab to FDA Approval

Several companies are developing potential treatments for Type 1 diabetes. Here's what the clinical trial process actually looks like and why it takes years to bring new therapies to patients.

Video report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsadvancements

Key takeaways

New Type 1 diabetes treatments go through multiple stages of research and testing before they reach patients
Clinical trials have three phases, each designed to test different aspects of safety and effectiveness
Phase 1 trials focus on safety, testing products on small groups of people to identify side effects
The entire process from initial research to FDA approval typically takes many years
Understanding this timeline helps explain why promising treatments aren't immediately available to everyone

The Long Journey: From Concept to Treatment

When you hear about a potential new treatment for Type 1 diabetes, it's often already been through years of work behind the scenes. Before any product ever reaches a human being, researchers spend considerable time in what's called the preclinical stage. This involves testing in computer simulations and animal studies to gather basic safety and effectiveness information.

What Are Clinical Trials?

Once preclinical work is complete, promising candidates move into clinical trials—the stage where products are tested on human volunteers. Clinical trials are organized into three distinct phases, each with a specific purpose. Understanding these phases helps explain why the path from promising research to available treatment takes time.

Phase 1: Safety First

Phase 1 trials are the first step in testing a new product on humans. These trials involve a small number of participants—typically anywhere from a couple of people to around 100. The primary goal is to assess safety: researchers want to understand whether the medication causes any unexpected or undesired side effects. Phase 1 trials also provide an initial look at how well the medication works and help identify the optimal dosing for future testing.

Beyond Phase 1: The Bigger Picture

Phase 1 is only the beginning. After Phase 1, successful candidates move through Phase 2 and Phase 3 trials, each involving larger groups of participants and more detailed testing of effectiveness. This multi-phase approach ensures that by the time a treatment reaches FDA review for approval, there's solid evidence of both safety and benefit. Companies like Vertex and Sanna are currently working through these stages with their Type 1 diabetes candidates, which is why these treatments remain in development rather than being available today.

Evidence label

Origin: YouTube / David Ahn, MD (Video report). Evidence: Video report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.